1. Home
  2. INDP vs BQ Comparison

INDP vs BQ Comparison

Compare INDP & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • BQ
  • Stock Information
  • Founded
  • INDP 2000
  • BQ 2008
  • Country
  • INDP United States
  • BQ China
  • Employees
  • INDP N/A
  • BQ N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • BQ Other Specialty Stores
  • Sector
  • INDP Health Care
  • BQ Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • BQ Nasdaq
  • Market Cap
  • INDP 5.0M
  • BQ 6.0M
  • IPO Year
  • INDP N/A
  • BQ 2020
  • Fundamental
  • Price
  • INDP $11.12
  • BQ $2.00
  • Analyst Decision
  • INDP Strong Buy
  • BQ
  • Analyst Count
  • INDP 2
  • BQ 0
  • Target Price
  • INDP $8.50
  • BQ N/A
  • AVG Volume (30 Days)
  • INDP 689.8K
  • BQ 42.2K
  • Earning Date
  • INDP 08-11-2025
  • BQ 07-07-2025
  • Dividend Yield
  • INDP N/A
  • BQ N/A
  • EPS Growth
  • INDP N/A
  • BQ N/A
  • EPS
  • INDP N/A
  • BQ N/A
  • Revenue
  • INDP N/A
  • BQ $81,208,354.00
  • Revenue This Year
  • INDP N/A
  • BQ N/A
  • Revenue Next Year
  • INDP N/A
  • BQ N/A
  • P/E Ratio
  • INDP N/A
  • BQ N/A
  • Revenue Growth
  • INDP N/A
  • BQ N/A
  • 52 Week Low
  • INDP $7.56
  • BQ $1.62
  • 52 Week High
  • INDP $67.48
  • BQ $7.40
  • Technical
  • Relative Strength Index (RSI)
  • INDP 98.13
  • BQ 45.05
  • Support Level
  • INDP $0.31
  • BQ $1.92
  • Resistance Level
  • INDP $0.71
  • BQ $2.17
  • Average True Range (ATR)
  • INDP 0.07
  • BQ 0.17
  • MACD
  • INDP 0.77
  • BQ -0.01
  • Stochastic Oscillator
  • INDP 99.09
  • BQ 29.84

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.

Share on Social Networks: